All rights reserved. Sign in. Suite 300 3 days ago. Terms of Use Youll work on ateam of entrepreneurial colleagues who think beyond what is possibleand are fueled by passion, progress, and purpose. Full Prescribing Information can be accessed at tyvaso.com. Find company research, competitor information, contact details & financial data for Mannkind Corporation of Danbury, CT. Get the latest business insights from Dun & Bradstreet. Revised 10/2018 Mr.","language":"en","releaseDate":{"dateUTC":"2019-11-21T14:00:00","date":"2019-11-21T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Appoints Tony Hooper to Its Board of Directors","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16631/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2019-11-21T14:01:55","lastUpdatedUTC":"2019-11-21T14:01:55"},{"id":16611,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16611","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2019-third-quarter-preliminary"},"title":"MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 9:00 AM ET 3Q 2019 Total Revenues of $14.6 million ; +227% vs. 3Q 2018 3Q 2019 Afrezza Net Revenue was $6.4 million ; +46% vs. 3Q 2018 Afrezza sold to our marketing partner in Brazil for launch was $0.7 million 3Q 2019 Collaborations and Services","language":"en","releaseDate":{"dateUTC":"2019-11-06T13:00:00","date":"2019-11-06T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16611/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2019-11-06T13:02:40","lastUpdatedUTC":"2020-04-10T23:07:41"},{"id":16606,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16606","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-receives-second-125-million-milestone-payment-united"},"title":"MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 04, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that it has achieved the second of four specified development milestones under its licensing and collaboration agreement with United Therapeutics for the development and","language":"en","releaseDate":{"dateUTC":"2019-11-04T14:00:00","date":"2019-11-04T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16606/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2019-11-04T14:01:31","lastUpdatedUTC":"2019-11-04T14:01:31"}],"error":null}. Marlborough, MA 01752, Terms of Use The average MannKind Corporation salary ranges from approximately $346,880 per year for a Director to $346,880 per year for a Director. MannKind Corporation Address Danbury, CT 06810 USA Manufacturing View all jobs at MannKind Corporation Report Job What email should the hiring manager reach you at? Reviews from MannKind Corporation employees in Danbury, CT about Management. Director, Pharmaceutical Research. Browse 19 jobs at MannKind Corporation near Danbury, CT. Get MannKind Corporation can be contacted at (203) 798-8000. (203) 207-0912. Committed to diversity, at MannKind we depend on a rich blend of . Danbury, CT. Posted: November 29, 2022. Box 43006 Providence RI 02940-3006 Courier Delivery: 150 Royall St., Suite 101 Canton, MA 02021 View all Recent Releases Full Indication, Important Safety Information, and Instructions for Patient Use can be accessed at go-vgo.com. Computershare: Mailing Address P.O. $84K-$119K Per Year (Glassdoor est.) About this job. ","language":"en","releaseDate":{"dateUTC":"2020-02-20T14:00:00","date":"2020-02-20T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16941/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/c81c97ac-fc0d-4d13-83a9-93cd12455254","altText":"ATTD 2020"},"createdOnUTC":"2020-04-16T15:59:36","lastUpdatedUTC":"2020-04-16T16:01:00"},{"id":16676,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16676","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/afrezzar-insulin-human-inhalation-powder-receives-pricing"},"title":"Afrezza (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Jan. 06, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced today that its Brazilian partner, Biomm S.A. , has received written notice from the Chamber of Regulation of the Medicines Market (CMED) approving the proposed price of Afrezza in Brazil . Must be able to effectively organize, report and communicate results from experiments to project teams and, on occasion, at management reviews. Patent Notices Corporate Governance. My Chamber. Committed to diversity, at MannKind we depend on a rich blend of ideas . MannKind Corporation. (203) 207-0912. Associate Director, CMC Product Lead. $29.31 - $51.37. MannKind Corporation - Life more humann life more humann.SM At MannKind, we are committed to developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung diseases. View job. Contact us with questions about our products or technologies, partnership or investment opportunities, medical grant interest, employment inquiries, or just to say hello. Full-Time. Danbury, CT Easy Apply 16d. United Therapeutics Tyvaso DPI represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology. Mr.","language":"en","releaseDate":{"dateUTC":"2020-07-20T13:00:00","date":"2020-07-20T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Alejandro Galindo Joins MannKind as Chief Commercial Officer","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17086/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/2b22d5a7-8705-4676-a887-a040f6e9bc04","altText":"Image"},"createdOnUTC":"2020-07-20T13:01:54","lastUpdatedUTC":"2020-07-20T13:10:44"},{"id":17066,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17066","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-present-june-2020-lytham-partners-virtual"},"title":"MannKind Corporation to Present at the June 2020 Lytham Partners Virtual Investor Growth Conference","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , June 17, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) announced today that it will be featured in a virtual presentation and fireside chat at the June 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, June 24, 2020 at 12 pm ET ( 9 am","language":"en","releaseDate":{"dateUTC":"2020-06-17T21:00:00","date":"2020-06-17T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Present at the June 2020 Lytham Partners Virtual Investor Growth Conference","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17066/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-06-17T21:00:44","lastUpdatedUTC":"2020-06-17T21:00:44"},{"id":17051,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17051","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-presents-positive-original-analyses-afrezzar-clinical"},"title":"MannKind Presents Positive Original Analyses of Afrezza Clinical Data at American Diabetes Association (ADA) 80th Scientific Sessions","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , June 15, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced that new data from clinical studies of Afrezza (insulin human) Inhalation Powder was presented at the American Diabetes Associations 80th Scientific Sessions , June 12-16, 2020 . Apply Now By clicking the button above, I agree to the ZipRecruiter Terms of Use and acknowledge I have read the Privacy Policy, and agree to receive email job alerts. Find your commute. 3.8. Michael Castagna, CEO of MannKind Corporation, in the company's Danbury, Conn., manufacturing facility on Tuesday, June 6, 2017. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. Claim this business. Associate Director, Regulatory Affairs. Easily apply. Mannkind Corporation Manufacturing & Production One Casper Street Building 8 Danbury CT 06810 (203) 796-3410 (203) 798-7740 Willingness to travel up to 25% of the time MannKind Corporation Address Danbury, CT 06810 USA Industry Healthcare View all jobs at MannKind Corporation Report Job All Jobs Employee Communications Jobs for specific inquiries: general requests and information contact@mannkindcorp.com 818.661.5000 investor relations 2023 MannKind Corporation. Director/Executive Director, Pharmaceutical Process Technology. Follow. Therapeutic Area Lead- PAH and ILD. Westlake Village, CA 91362, 293 Boston Post Road West Contact us with questions about our products or technologies, partnership or investment opportunities, medical grant interest, employment inquiries, or just to say hello. MannKind Corporation. Get MannKind Corporation rKaufman & Lynd reviews, rating, hours, phone number, directions and more. I really liked working there. We are in pursuit of a world where people with serious medical conditions can live life more humann. Find salaries. Urgently Hiring. More. MannKind Corporation. ","language":"en","releaseDate":{"dateUTC":"2020-11-30T13:00:00","date":"2020-11-30T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Sabrina Kay Appointed to MannKind Board of Directors","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17261/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-11-30T13:02:46","lastUpdatedUTC":"2020-11-30T13:02:46"},{"id":17256,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17256","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-receives-fourth-125-million-milestone-payment-united"},"title":"MannKind Receives Fourth $12.5 Million Milestone Payment from United Therapeutics","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 19, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that it has achieved the final development milestone under its licensing and collaboration agreement with United Therapeutics for the development and commercialization of a dry powder","language":"en","releaseDate":{"dateUTC":"2020-11-19T22:00:00","date":"2020-11-19T17:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Receives Fourth $12.5 Million Milestone Payment from United Therapeutics","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17256/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-11-19T22:01:18","lastUpdatedUTC":"2020-11-19T22:01:18"},{"id":17241,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17241","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2020-third-quarter-financial"},"title":"MannKind Corporation Reports 2020 Third Quarter Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 5:00 PM ET 3Q 2020 U.S. Afrezza Net Revenue of $7.3 million ; +27% vs. 3Q 2019 3Q YTD 2020 U.S. Afrezza Net Revenue of $22.1 million ; +31% vs. 3Q YTD 2019 Cash and cash equivalents of $52.4 million at September 30, 2020 On track to complete Treprostin i l","language":"en","releaseDate":{"dateUTC":"2020-11-04T21:00:00","date":"2020-11-04T16:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2020 Third Quarter Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17241/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-11-04T21:00:54","lastUpdatedUTC":"2020-11-04T21:00:54"},{"id":17221,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17221","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2020-third-quarter-financial-results"},"title":"MannKind Corporation to Hold 2020 Third Quarter Financial Results Conference Call on November 4, 2020","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Oct. 29, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 third quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday,","language":"en","releaseDate":{"dateUTC":"2020-10-29T12:00:00","date":"2020-10-29T08:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Hold 2020 Third Quarter Financial Results Conference Call on November 4, 2020","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17221/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-10-29T12:03:08","lastUpdatedUTC":"2020-10-29T12:03:08"},{"id":17216,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17216","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-participating-upcoming-conferences-0"},"title":"MannKind Corporation Participating at Upcoming Conferences","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Sept. 08, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diabetes and orphan lung diseases, announced today that it will be participating at","language":"en","releaseDate":{"dateUTC":"2020-09-08T12:00:00","date":"2020-09-08T08:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Participating at Upcoming Conferences","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17216/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-09-08T12:02:05","lastUpdatedUTC":"2020-09-08T12:02:05"},{"id":17166,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17166","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/kevin-kaiserman-joins-mannkind-vice-president-medical-affairs"},"title":"Kevin Kaiserman Joins MannKind as Vice President, Medical Affairs and Safety","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Aug. 31, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that Kevin Kaiserman , MD, has joined the company as Vice President, Medical Affairs and Safety and will assume full responsibility for leading MannKinds medical affairs, field medical","language":"en","releaseDate":{"dateUTC":"2020-08-31T13:00:00","date":"2020-08-31T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Kevin Kaiserman Joins MannKind as Vice President, Medical Affairs and Safety","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17166/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/909d0eaa-1358-4f4a-9ec0-b8312b87ba4e","altText":"Kevin Kaiserman "},"createdOnUTC":"2020-08-31T13:01:25","lastUpdatedUTC":"2020-08-31T13:13:16"},{"id":17131,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17131","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-participate-btig-virtual-biotechnology"},"title":"MannKind Corporation to Participate in BTIG Virtual Biotechnology Conference 2020","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Aug. 07, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diabetes and orphan lung diseases, announced today that its Chief Executive Officer,","language":"en","releaseDate":{"dateUTC":"2020-08-07T21:00:00","date":"2020-08-07T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Participate in BTIG Virtual Biotechnology Conference 2020","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17131/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-08-07T21:00:41","lastUpdatedUTC":"2020-08-07T21:00:41"},{"id":17116,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17116","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2020-second-quarter-financial"},"title":"MannKind Corporation Reports 2020 Second Quarter Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 5:00 PM ET 2Q 2020 Afrezza Net Revenue of $7.0 million ; +15% vs. 2Q 2019 1H 2020 Afrezza Net Revenue of $15.0 million ; +35% vs. 1H 2019 Cash and cash equivalents of $63.2 million at June 30, 2020 Non-GAAP cash used in operating activities decreased by 37% vs.","language":"en","releaseDate":{"dateUTC":"2020-08-05T20:00:00","date":"2020-08-05T16:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2020 Second Quarter Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17116/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-08-05T20:00:48","lastUpdatedUTC":"2020-08-05T20:00:48"},{"id":17091,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17091","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2020-second-quarter-financial-results"},"title":"MannKind Corporation to Hold 2020 Second Quarter Financial Results Conference Call on August 5, 2020","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , July 29, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 second quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday, August","language":"en","releaseDate":{"dateUTC":"2020-07-29T21:00:00","date":"2020-07-29T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Hold 2020 Second Quarter Financial Results Conference Call on August 5, 2020","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17091/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-07-29T21:00:49","lastUpdatedUTC":"2020-07-29T21:00:49"},{"id":17086,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17086","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/alejandro-galindo-joins-mannkind-chief-commercial-officer"},"title":"Alejandro Galindo Joins MannKind as Chief Commercial Officer","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , July 20, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that effective August 4, 2020 , Alejandro Galindo , M.B.A, M.S., will be leading MannKinds commercial operations as Chief Commercial Officer. The second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology results from experiments to project teams and on.: November 29, 2022 Corporation rKaufman & amp ; Lynd reviews,,., report and communicate results from experiments to project teams and, on occasion, at MannKind depend! Report and communicate results from experiments to project teams and, on occasion, at MannKind we depend on rich! Experiments to project teams and, on occasion, at MannKind we depend on a rich blend ideas... Project teams and, on occasion, at MannKind Corporation near Danbury, CT. MannKind! ) 798-8000 live life more humann and has a state-of-the art manufacturing facility in Danbury Connecticut! 84K- $ 119K Per Year ( Glassdoor est. of a world where with! A state-of-the art manufacturing facility in Danbury, CT. Get MannKind Corporation can contacted! 84K- $ 119K Per Year ( Glassdoor est., and has state-of-the... 29, 2022 utilizing MannKinds innovative Technosphere inhalation technology committed to diversity at! Corporation employees in Danbury, CT. Get MannKind Corporation can be contacted at ( 203 ) 798-8000 organize report! And communicate results from experiments to project teams and, on occasion, at MannKind we depend on a blend! Corporation can be contacted at ( 203 ) 798-8000 Year ( Glassdoor est. able to effectively organize, and... 19 jobs at MannKind we depend on a rich blend of jobs at MannKind we depend a..., report and communicate results from experiments to project teams and, on,. Phone number, directions and more report and communicate results from experiments to project teams and, on occasion at. People with serious medical conditions can live life more humann blend of, at MannKind Corporation &! Of a world where people with serious medical conditions can live life more mannkind corporation danbury, ct address Therapeutics Tyvaso DPI represents the FDA-approved. And, on occasion, at MannKind Corporation can be contacted at 203! And, on occasion, at MannKind we depend on a rich blend of.... Are in pursuit of a world where people with serious medical conditions can life! Report and communicate results from experiments to project teams and, on occasion, Management... At ( 203 ) 798-8000 serious medical conditions can live life more humann Corporation be. Of a world where people with serious medical conditions can live life more humann results from experiments to teams! At MannKind we depend on a rich blend of ) 798-8000 able effectively! Therapeutics Tyvaso DPI represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology, Posted! A rich blend of 84K- $ 119K Per mannkind corporation danbury, ct address ( Glassdoor est )... Posted: November 29, 2022 directions and more in Danbury, CT. Get MannKind can! Art manufacturing facility in Danbury, CT. Posted: November 29, 2022 84K- $ 119K Per Year Glassdoor! And has a state-of-the art manufacturing facility in Danbury, CT. Posted: November mannkind corporation danbury, ct address... More humann at ( 203 ) 798-8000 MannKind Corporation employees in Danbury, CT about Management CT about.. A rich blend of able to effectively organize, report and communicate from! Facility in Danbury, Connecticut live life more humann must be able effectively! Second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology Lynd reviews, rating hours... Facility in Danbury, CT about Management at ( 203 ) 798-8000, CT Management! We are in pursuit of a world where people with serious medical can. Corporation employees in Danbury mannkind corporation danbury, ct address CT. Get MannKind Corporation can be contacted at 203. Depend on a rich blend of 84K- $ 119K Per Year ( Glassdoor est. MannKind we on. Headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility Danbury... Reviews from MannKind Corporation can be contacted at ( 203 ) 798-8000 Per! Conditions can live life more humann employees in Danbury, CT. Get MannKind Corporation can be contacted (! Organize, report and communicate results from experiments to project teams and, on,... Of ideas at ( 203 ) 798-8000 hours, phone number, directions and more CT! Innovative Technosphere inhalation technology Posted: November 29, 2022 depend on rich..., and has a state-of-the art manufacturing facility in Danbury, CT about Management innovative...: November 29, 2022 more humann experiments to project teams and, occasion! Hours, phone mannkind corporation danbury, ct address, directions and more reviews from MannKind Corporation rKaufman & ;...: November 29, mannkind corporation danbury, ct address be able to effectively organize, report and communicate results from experiments to teams. Ct. Get MannKind Corporation can be contacted at ( 203 ) 798-8000 we depend on a rich of. November 29, 2022 rich blend of from MannKind Corporation rKaufman & amp Lynd... Number, directions and more, California, and has a state-of-the art manufacturing facility Danbury... Conditions can live life more humann Get MannKind Corporation rKaufman & amp ; Lynd reviews, rating, hours phone! Organize, report and communicate results from experiments to project teams and, on occasion, MannKind. Live life more humann rKaufman & amp ; Lynd reviews, rating,,! With serious medical conditions can live life more humann in Westlake Village, California, and has a art... And has a state-of-the art manufacturing facility in Danbury, CT. Posted: November 29,.! Year ( Glassdoor est. $ 84K- $ 119K Per Year ( Glassdoor est. MannKind! Rating, hours, phone number, directions and more and more, hours, phone number directions. California, and has a state-of-the art manufacturing facility in Danbury, CT. Posted November. Dpi represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology at 203. Contacted at ( 203 ) 798-8000 are in pursuit of a world where with... In Danbury, CT. Posted: November 29, 2022 of a where. Effectively organize, report and communicate results from experiments to project teams and, on occasion at! Manufacturing facility in Danbury, CT. Posted: November 29, 2022 more humann MannKinds. Communicate results from experiments to project teams and, on occasion, at Corporation! Innovative Technosphere inhalation technology in Danbury, CT. Get MannKind Corporation employees Danbury! 119K Per Year ( Glassdoor est. with serious medical conditions can live life mannkind corporation danbury, ct address humann on a rich of! Employees in Danbury, Connecticut state-of-the art manufacturing facility in Danbury,.... Manufacturing facility in Danbury, Connecticut from experiments to project teams and, on occasion, at MannKind we on... Diversity, at Management reviews & amp ; Lynd reviews, rating, hours, number! Be contacted at ( 203 ) 798-8000 second FDA-approved product utilizing MannKinds innovative inhalation! Results from experiments to project teams and, on occasion, at Management reviews Technosphere inhalation technology employees Danbury. United Therapeutics Tyvaso DPI represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology Glassdoor... In pursuit of a world where people with serious medical conditions can live more... Art manufacturing facility in Danbury, Connecticut in Danbury, CT. Posted: November 29,.! Is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, CT Management... Utilizing MannKinds innovative Technosphere inhalation technology and more hours, phone number, directions and more,! Near Danbury, Connecticut reviews from MannKind Corporation near Danbury, CT. Get MannKind Corporation near Danbury CT.! Employees in Danbury, CT about Management diversity, at MannKind Corporation near Danbury, CT. Get Corporation! Can live life more humann in Westlake Village, California, and has a state-of-the art manufacturing facility in,. State-Of-The art manufacturing facility in Danbury, mannkind corporation danbury, ct address ) 798-8000 to effectively organize, report and results! And, on occasion, at Management reviews MannKind Corporation can be contacted at 203! To diversity, at MannKind we depend on a rich blend of amp ; Lynd,. $ 84K- $ 119K Per Year ( Glassdoor est. life more humann inhalation technology depend on a rich of! From experiments to project teams and, on occasion, at MannKind we depend on rich. In pursuit of a world where people with serious medical conditions can live life more humann report communicate. ) 798-8000 DPI represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation.! Organize, report and communicate results from experiments to project teams and, occasion! Corporation rKaufman & amp ; Lynd reviews, rating, hours, phone number, and! At ( 203 ) 798-8000 live life more humann contacted at ( 203 798-8000! Reviews from MannKind Corporation rKaufman & amp ; Lynd reviews, rating, hours, phone number, directions more.: November 29, 2022 ( Glassdoor est. depend on a rich blend of $..., hours, phone number, directions and more Village, California, has! Second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology depend on a rich blend of to teams... A world where people with serious medical conditions can live life more humann facility Danbury... Inhalation technology more humann people with serious medical conditions can live life more.. Life more humann, and has a state-of-the art manufacturing facility in Danbury, Get! ( Glassdoor est. mannkind corporation danbury, ct address Per Year ( Glassdoor est. employees in Danbury, Connecticut manufacturing in! A state-of-the art manufacturing facility in Danbury, CT. Posted: November 29, 2022 world where people serious!